Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study

Circulation

Volumn 92, Issue 4, 1995, Pages 785-789

  Maron, Barry J ^a   Gardin, Julius M ^b   Flack, John M ^b   Gidding, Samuel S ^b   Kurosaki, Tom T ^b   Bild, Diane E ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b NONE

Author keywords

cardiomyopathy; echocardiography; hypertrophy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

EID: 0029083650     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.4.785     Document Type: Article

References (43)

1. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316: 780-789, 844-852.
2. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985;28:1-83.
3. Braunwald E, Lambrew CT, Rockoff SD, Ross J, Morrow AG. Idiopathic hypertrophic subaortic stenosis, I: a description of the disease based upon an analysis of 64 patients. Circulation. 1964; 30(suppl IV):IV-3-IV-119.
4. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment of M-mode and two-dimensional echocardiography. Am J Cardiol. 1984;53:1087-1094.
5. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418-428.
6. Watkins H, Rosenzweig A, Hwang D-S, Levi T, McKenna WJ, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-1114.
7. Roberts CS, Roberts WC. Morphologic features. In: Zipes DP, Rowlands DJ, eds. Progress in Cardiology 2/2. Philadelphia. Pa: Lea & Febiger; 1989:3-22.
8. Ciró E, Nichols PF, Maron BJ. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation. 1983;67: 1227-1233.
9. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:489-497.
10. Teare D. Asymmetrical hypertrophy of the heart in young patients. Br Heart J. 1958;20:1-18.
11. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: profile of 78 patients. Circulation. 1982;65: 1388-1394.
12. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation. 1980;62:218-229.
13. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in the competitive athlete. J Am Coll Cardiol. 1986;7:204-214.
14. Maron BJ, Shirani J, Muellcr FO, Cantu RC, Roberts WC. Cardiovascular causes of 'athletic field' deaths: analysis of sudden death in 84 competitive athletes. Circulation. 1993;88:1-50. Abstract.
15. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation. 1968;37:759-788.
16. Shah PM, Adelman AG, Wigle ED, Gobel FL, Burchell HG, Hardarson T, Curiel R, de la Calzada C, Oakley CM, Goodwin JF. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Cire Res. 1974;34,35(suppl II):II-179-II-195.
17. McKenna WJ, Deanfield JE, Faroqui A, England D, Oakley C, Goodwin JF. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, clectrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532-538.
18. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation. 1989;80: 1489-1492.
19. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990;15:1521-1526.
20. Maron BJ, Bodison S, Wesley Y, Tucker E, Green KJ. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 1987;10:1214-1222.
21. Lewis JF, Maron BJ, Diggs JA, Spencer JE, Mehrotra PP, Curry CL. Preparticipation echocardiographic screening for cardiovascular disease in a large predominantly black population of collegiate athletes. Am J Cardiol. 1989;64:1029-1033.
22. Swan DA, Bell B, Oakley C, Goodwin JF. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 1971;33:671-685.
23. Adelman AG, Wigle ED, Ranganthan N, Webb GD, Kidd BSL, Bigelow WG, Silver MD. The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 hemodynamically proved cases. Ann Intern Med. 1972;77:515-525.
24. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749-755.
25. Maron BJ, Spirito P. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol. 1993;72:970-972.
26. Freidman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, Liu K, Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105-1116.
27. Gardin JM, Wong ND, Bommer W, Klopfenstein HS, Smith V-E, Tabatznik B, Siscovick D, Lobodzinski S, Anton-Culver H, Manolio T. Echocardiographic design of a multi-center investigation of freeliving elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr. 1992;5:63-72.
28. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
29. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT. Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Mayo Clin Proc. 1978;53:271-303.
30. Spirito P, Maron BJ, Chiarella F, Bellotti P, Tramarin R, Pozzoli M, Vecchio C. Diastolic abnormalities in patients with hypertrophic cardiomvopathy: relation to magnitude of left ventricular hypertrophy. Circulation. 1985;72:310-316.
31. Gilbert BW, Polliek C, Adclman AG, Wigle ED. Hypertrophic cardiomyopathy: subclassification by M-mode echocardiography. Am J Cardiol. 1980;45:861-872.
32. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979;43:1242-1244.
33. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980;62:1054-1061.
34. Shah PM, Gramiak R, Kramer DH. Ultrasound location of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation. 1969;40:3-11.
35. Spirito P, Maron BJ. Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment of two-dimensional echocardiography. Am J Cardiol. 1984;54:1039-1046.
36. Maron BJ, Harding AM, Spirito P, Roberts WC, Waller BF. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in hypertrophic cardiomyopathy. Circulation. 1983;68:282-293.
37. Lewis JF, Maron BJ. Diversity of patterns of left ventricular wall thickening in patients with systemic hypertension and marked hypertrophy. Am J Candiol. 1990;65:874-881.
38. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614.
39. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: clinical significance, functional and morphologic features. J Am Coll Cardiol. 1986;8:57-65.
40. Hada Y, Sakamoto T, Amano K, Yamaguchi T, Takenaka K, Takahashi H, Takikawa R, Hasegawa I, Takahashi T, Suzuki J-I, Sugimoto T, Saito K-I. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. Am J Cardiol. 1987;59:183-184.
41. Savage DD, Castelli WP, Abbott RD, Garrison RJ, Anderson SJ, Kanell WB, Feinleib M. Hypertrophic cardiomyopathy and its markers in the general population: the great masquerader revisited: the Framingham Study. J Cardiovasc Ultrason. 1983;2:41-47.
42. Maron BJ, Peterson EE, Maron MS, Peterson JE. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol. 1994;73:577-580.
43. Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-based study in Olmsted County. Minnesota, 1975-1984. Circulation. 1989;80: 564-572.